| 2012-12 |
Antimigratory effects of the methanol extract from Momordica charantia on human lung adenocarcinoma CL1 cells |
Evidence-based Complementary and Alternative Medicine. 2012 Dec;2012:Article ID 819632. |
 |
| 2015-08 |
Antimitotic and antivascular activity of heteroaroyl-2-hydroxy-3,4,5-trimethoxybenzenes |
Bioorganic and Medicinal Chemistry. 2015 Aug;23(15):4230-4236. |
|
| 2013-06 |
An antimitotic and antivascular agent BPR0L075 overcomes multidrug resistance and induces mitotic catastrophe in paclitaxel-resistant ovarian cancer cells |
PLoS ONE. 2013 Jun;8(6):Article number e65686. |
|
| 2014-04 |
Antimitotic and vascular disrupting agents: 2-hydroxy-3,4,5-trimethoxybenzophenones |
European Journal of Medicinal Chemistry. 2014 Apr 22;77(2):306-314. |
|
| 2011-06 |
Antimutagenic constituents of adlay ( Coix lachryma-jobi L. var. ma-yuen Stapf) with potential cancer chemopreventive activity |
Journal of Agricultural and Food Chemistry. 2011 Jun;59(12):6444-6452. |
|
| 1999-04 |
Antineoplastic effect of interferon beta is associated with apoptosis pathway in human colon adenocarcinoma cell line |
FASEB Journal. 1999 Apr;13(7):A1342. |
|
| 2013-05 |
Antioxidant relevance to human health |
Asia Pacific Journal of Clinical Nutrition. 2013 May;22(2):171-176. |
|
| 2010-06 |
Antioxidants from the leaves of cinnamomum kotoense |
Natural Product Communications. 2010 Jun;5(6):911-912. |
|
| 2010-09 |
Antiproliferative effect of LXR agonists T0901317 and 22(R)-Hydroxycholesterol on multiple human cancer cell lines |
Anticancer Research. 2010 Sep;30(9):3643-3648. |
|
| 2011-10 |
Antiproliferative effects of N-heterocyclic indolyl glyoxylamide derivatives on human lung cancer cells |
Anticancer Research. 2011 Oct;31(10):3407-3415. |
|
| 2014-10 |
Antipsychotic drug and seizure risk among patients with psychotic or mood disorder in Taiwan |
Pharmacoepidemiology and Drug Safety. 2014 Oct;23(S1):272. |
|
| 2015-02-23 |
Antipsychotic drugs and the risk of ventricular arrhythmia and/or sudden cardiac death: A nation-wide case-crossover study |
Journal of the American Heart Association. 2015 Feb 23;4(2):Article number e001568. |
|
| 2013-09 |
Antipsychotic treatment and the occurrence of venous thromboembolism: A 10-year nationwide registry study |
Journal of Clinical Psychiatry. 2013 Sep;74(9):918-924. |
|
| 2015-09 |
Antipsychotic treatment and the risk of hip fracture in subjects with schizophrenia: A 10-Year population-based case-control study |
Journal of Clinical Psychiatry. 2015 Sep;76(9):1216-1223. |
|
| 2012-06 |
Antiretroviral drug resistance among treatment-naïve HIV-1 patients in southern Taiwan |
International Journal of Infectious Diseases. 2012 Jun;16(Suppl 1):e192. |
|
| 2011-01 |
Antitubercular resorcinol analogs and benzenoid C-glucoside from the roots of ardisia cornudentata |
Planta Medica. 2011 Jan;77(1):60-65. |
|
| 2009-12 |
Antitubercular resorcinols and cytotoxic alkyl benzoquinones from Ardisia kusukuensis |
Taiwan Pharmaceutical Journal. 2009 Dec;61(4):89-105. |
|
| 2006-05 |
Antitubulin agents for the treatment of cancer - a medicinal chemistry update |
Expert Opinion on Therapeutic Patents. 2006 May;16(5):647-691. |
|
| 2010-02 |
Antitumor activities and pharmacokinetics of silatecans DB-67 and DB-91 |
Pharmacological Research. 2010 Feb;61(2):108-115. |
|
| 2011-12 |
Antitumor activity of a novel histone deacetylase inhibitor (S)-HDAC42 in oral squamous cell carcinoma |
Oral Oncology. 2011 Dec;47(12):1127-1133. |
|
| 2002-09-26 |
Antitumor AHMA linked to DNA minor groove binding agents: Synthesis and biological evaluation |
Journal of Medicinal Chemistry. 2002 Sep;45(20):4485-4493. |
|
| 2003-07-15 |
Antitumor and antimetastatic activity of IL-23 |
Journal of Immunology. 2003 Jul;171(2):600-607. |
|
| 2011-04 |
Antitumor effect of BPR-DC-2, a novel synthetic cyclic cyanoguanidine derivative, involving the inhibition of MDR-1 expression and down-regulation of p-AKT and PARP-1 in lung cancer |
Investigational New Drugs. 2011 Apr;29(2):195-206. |
|
| 2006-09-01 |
Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer |
Clinical Cancer Research. 2006 Sep;12(17):5199-5206. |
|
| 2024-04-19 |
Antitumor efficacy of arylquin 1 through dose-dependent cytotoxicity, apoptosis induction, and synergy with radiotherapy in glioblastoma models |
Biomedicines. 2024 Apr 19;12(4):Article number 907. |
|
